{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Hawthorne",
      "state": "CA",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "95994",
      "recalling_firm": "SHOPPERS- PLAZA",
      "address_1": "Fouad Panchibyaya 12816",
      "address_2": "",
      "postal_code": "90250",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide via internet sales",
      "recall_number": "D-0207-2025",
      "product_description": "FOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza, Hawthorne, CA 90250. Product of India. UPC 8 26656 69047 7",
      "product_quantity": "172 180-count bottles",
      "reason_for_recall": "Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide",
      "recall_initiation_date": "20241216",
      "center_classification_date": "20250122",
      "report_date": "20250129",
      "code_info": "Batch # 001, exp. date 09/10/2026",
      "more_code_info": ""
    }
  ]
}